CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
暂无分享，去创建一个
David N Sheppard | Uta Griesenbach | David J Porteous | D. Porteous | Seng H. Cheng | J. Davies | S. Abdullah | L. Davies | S. Hyde | G. Nunez-Alonso | R. Bazzani | I. Pringle | A. Lawton | S. Sumner-Jones | D. Gill | E. Alton | N. Yew | D. Sheppard | Hongyu Li | Jane C Davies | A. Varathalingam | Stephen C Hyde | Ian A Pringle | Syahril Abdullah | Anna E Lawton | Lee A Davies | Anusha Varathalingam | Graciela Nunez-Alonso | Anne-Marie Green | Reto P Bazzani | Stephanie G Sumner-Jones | Mario Chan | Hongyu Li | Nelson S Yew | Seng H Cheng | A Christopher Boyd | Felix M Munkonge | Eric W F W Alton | Deborah R Gill | U. Griesenbach | A. Boyd | F. Munkonge | Anne-Marie Green | M. Chan
[1] J. Olesen,et al. Resource allocation to brain research in Denmark: an example for other European countries , 2007, European journal of neurology.
[2] S. Hyde,et al. Detection of plasmid DNA vectors following gene transfer to the murine airways , 2005, Gene Therapy.
[3] C. Higgins,et al. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor1α promoter , 2001, Gene Therapy.
[4] J. Clancy,et al. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. , 2001, Human gene therapy.
[5] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[6] D. Gill,et al. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis , 2000, Gene Therapy.
[7] Seng H. Cheng,et al. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[8] D. Davidson,et al. Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs , 2000, Gene Therapy.
[9] A. Tucker,et al. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. , 1999, The Journal of clinical investigation.
[10] S. Durham,et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial , 1999, The Lancet.
[11] R. Scheule,et al. A concentrated and stable aerosol formulation of cationic lipid:DNA complexes giving high-level gene expression in mouse lung. , 1997, Human gene therapy.
[12] D. Porteous,et al. A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. , 1996, Gene therapy.
[13] F. Wu,et al. A DNA segment conferring stable maintenance on R6K gamma-origin core replicons , 1995, Journal of bacteriology.
[14] G. Bishop,et al. CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.